476 related articles for article (PubMed ID: 28402516)
1. Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial.
Fam MD; Hanley D; Stadnik A; Zeineddine HA; Girard R; Jesselson M; Cao Y; Money L; McBee N; Bistran-Hall AJ; Mould WA; Lane K; Camarata PJ; Zuccarello M; Awad IA
Neurosurgery; 2017 Nov; 81(5):860-866. PubMed ID: 28402516
[TBL] [Abstract][Full Text] [Related]
2. Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure.
Awad IA; Polster SP; Carrión-Penagos J; Thompson RE; Cao Y; Stadnik A; Money PL; Fam MD; Koskimäki J; Girard R; Lane K; McBee N; Ziai W; Hao Y; Dodd R; Carlson AP; Camarata PJ; Caron JL; Harrigan MR; Gregson BA; Mendelow AD; Zuccarello M; Hanley DF;
Neurosurgery; 2019 Jun; 84(6):1157-1168. PubMed ID: 30891610
[TBL] [Abstract][Full Text] [Related]
3. A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III).
Ziai WC; McBee N; Lane K; Lees KR; Dawson J; Vespa P; Thompson RE; Mendelow AD; Kase CS; Carhuapoma JR; Thompson CB; Mayo SW; Reilly P; Janis S; Anderson CS; Harrigan MR; Camarata PJ; Caron JL; Zuccarello M; Awad IA; Hanley DF;
Int J Stroke; 2019 Jul; 14(5):548-554. PubMed ID: 30943878
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis for Evacuation of Intracerebral and Intraventricular Hemorrhage: A Guide to Surgical Protocols With Practical Lessons Learned From the MISTIE and CLEAR Trials.
Polster SP; Carrión-Penagos J; Lyne SB; Goldenberg FD; Mansour A; Ziai W; Carlson AP; Camarata PJ; Caron JL; Harrigan MR; Gregson B; Mendelow AD; Zuccarello M; Hanley DF; Dodd R; Awad IA
Oper Neurosurg (Hagerstown); 2020 Dec; 20(1):98-108. PubMed ID: 33313847
[TBL] [Abstract][Full Text] [Related]
5. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema.
Mould WA; Carhuapoma JR; Muschelli J; Lane K; Morgan TC; McBee NA; Bistran-Hall AJ; Ullman NL; Vespa P; Martin NA; Awad I; Zuccarello M; Hanley DF;
Stroke; 2013 Mar; 44(3):627-34. PubMed ID: 23391763
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.
Hanley DF; Thompson RE; Muschelli J; Rosenblum M; McBee N; Lane K; Bistran-Hall AJ; Mayo SW; Keyl P; Gandhi D; Morgan TC; Ullman N; Mould WA; Carhuapoma JR; Kase C; Ziai W; Thompson CB; Yenokyan G; Huang E; Broaddus WC; Graham RS; Aldrich EF; Dodd R; Wijman C; Caron JL; Huang J; Camarata P; Mendelow AD; Gregson B; Janis S; Vespa P; Martin N; Awad I; Zuccarello M;
Lancet Neurol; 2016 Nov; 15(12):1228-1237. PubMed ID: 27751554
[TBL] [Abstract][Full Text] [Related]
7. End-of-Treatment Intracerebral and Ventricular Hemorrhage Volume Predicts Outcome: A Secondary Analysis of MISTIE III.
de Havenon A; Joyce E; Yaghi S; Ansari S; Delic A; Taussky P; Alexander M; Tirschwell D; Grandhi R
Stroke; 2020 Feb; 51(2):652-654. PubMed ID: 31842688
[TBL] [Abstract][Full Text] [Related]
8. Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial.
Morgan T; Zuccarello M; Narayan R; Keyl P; Lane K; Hanley D
Acta Neurochir Suppl; 2008; 105():147-51. PubMed ID: 19066101
[TBL] [Abstract][Full Text] [Related]
9. Modern Approaches to Evacuating Intracerebral Hemorrhage.
Bhatia K; Hepburn M; Ziu E; Siddiq F; Qureshi AI
Curr Cardiol Rep; 2018 Oct; 20(12):132. PubMed ID: 30311010
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis.
Newell DW; Shah MM; Wilcox R; Hansmann DR; Melnychuk E; Muschelli J; Hanley DF
J Neurosurg; 2011 Sep; 115(3):592-601. PubMed ID: 21663412
[TBL] [Abstract][Full Text] [Related]
11. Legacy of MISTIE III.
Sigounas D
World Neurosurg; 2019 Jun; 126():589-590. PubMed ID: 31546318
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.
Hanley DF; Thompson RE; Rosenblum M; Yenokyan G; Lane K; McBee N; Mayo SW; Bistran-Hall AJ; Gandhi D; Mould WA; Ullman N; Ali H; Carhuapoma JR; Kase CS; Lees KR; Dawson J; Wilson A; Betz JF; Sugar EA; Hao Y; Avadhani R; Caron JL; Harrigan MR; Carlson AP; Bulters D; LeDoux D; Huang J; Cobb C; Gupta G; Kitagawa R; Chicoine MR; Patel H; Dodd R; Camarata PJ; Wolfe S; Stadnik A; Money PL; Mitchell P; Sarabia R; Harnof S; Barzo P; Unterberg A; Teitelbaum JS; Wang W; Anderson CS; Mendelow AD; Gregson B; Janis S; Vespa P; Ziai W; Zuccarello M; Awad IA;
Lancet; 2019 Mar; 393(10175):1021-1032. PubMed ID: 30739747
[TBL] [Abstract][Full Text] [Related]
13. Emergency Free-Hand Bedside Catheter Evacuation of Large Intracerebral Hematomas Following Thrombolysis for Ischemic Stroke: A Case Series.
Bardutzky J; Shah M; Lambeck J; Meckel S; Niesen WD
Neurocrit Care; 2020 Aug; 33(1):207-217. PubMed ID: 31797279
[TBL] [Abstract][Full Text] [Related]
14. Letter: Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure.
Feng Z; Tan Q; Chen Z
Neurosurgery; 2020 Apr; 86(4):E410. PubMed ID: 31813970
[No Abstract] [Full Text] [Related]
15. In Reply: Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure.
Polster SP; Awad IA
Neurosurgery; 2020 Apr; 86(4):E411. PubMed ID: 31813968
[No Abstract] [Full Text] [Related]
16. Minimally Invasive Surgery With Thrombolysis for Intracerebral Hemorrhage Evacuation: Bayesian Reanalysis of a Randomized Controlled Trial.
Bako AT; Potter T; Pan AP; Tannous J; Britz G; Ziai WC; Awad I; Hanley D; Vahidy FS
Neurology; 2023 Oct; 101(16):e1614-e1622. PubMed ID: 37684058
[TBL] [Abstract][Full Text] [Related]
17. Frameless stereotactically guided catheter placement and fibrinolytic therapy for spontaneous intracerebral hematomas: technical aspects and initial clinical results.
Rohde V; Rohde I; Reinges MH; Mayfrank L; Gilsbach JM
Minim Invasive Neurosurg; 2000 Mar; 43(1):9-17. PubMed ID: 10794561
[TBL] [Abstract][Full Text] [Related]
18. Future perspectives on the fibrinolytic therapy of intracerebral hemorrhages.
Thiex R
Cent Nerv Syst Agents Med Chem; 2011 Jun; 11(2):150-6. PubMed ID: 21521167
[TBL] [Abstract][Full Text] [Related]
19. Long-term functional outcome following minimally invasive endoscopic intracerebral hemorrhage evacuation.
Kellner CP; Song R; Pan J; Nistal DA; Scaggiante J; Chartrain AG; Rumsey J; Hom D; Dangayach N; Swarup R; Tuhrim S; Ghatan S; Bederson JB; Mocco J
J Neurointerv Surg; 2020 May; 12(5):489-494. PubMed ID: 31915207
[TBL] [Abstract][Full Text] [Related]
20. Comparison of frame-based and frameless stereotactic hematoma puncture and subsequent fibrinolytic therapy for the treatment of supratentorial deep seated spontaneous intracerebral hemorrhage.
Kim IS; Son BC; Lee SW; Sung JH; Hong JT
Minim Invasive Neurosurg; 2007 Apr; 50(2):86-90. PubMed ID: 17674294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
